Alan Rubino
Director/Board Member presso VERICEL CORPORATION
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Alan L.
Rubino was the founder of Akrimax Pharmaceuticals LLC (founded in 2007) and New American Therapeutics, Inc. (founded in 2010) where he held the titles of President & Chief Executive Officer.
Currently, he is the Chairman at AMO Pharma Ltd.
and an Independent Director at Vericel Corp., Director at HealthCare Institute of New Jersey, and Director at Genisphere LLC.
His former positions include President, Chief Executive Officer & Director at Emisphere Technologies, Inc. (2012-2019), Chairman, President & Chief Executive Officer at RenovaCare, Inc. (2019-2021), Director at BioNJ, Inc. (2014), Independent Director at SANUWAVE Health, Inc. (2003-2021), President & Chief Operating Officer at W World Corp.
(2005-2007), Executive Vice President & General Manager at Interpace Biosciences, Inc. (2004-2005), and Senior Executive Officer at Genentech, Inc. and Hoffmann-La Roche Ltd.
He received his undergraduate degree from Rutgers State University of New Jersey in 1976.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VERICEL CORPORATION
0.04% | 09/04/2024 | 20 594 ( 0.04% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Alan Rubino
| Società | Posizione | Inizio |
|---|---|---|
| VERICEL CORPORATION | Director/Board Member | 28/09/2005 |
Genisphere LLC
 Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Director/Board Member | 01/05/2010 |
| HealthCare Institute of New Jersey | Director/Board Member | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Chairman | 16/08/2021 |
Precedenti posizioni note di Alan Rubino
| Società | Posizione | Fine |
|---|---|---|
| SANUWAVE HEALTH, INC. | Director/Board Member | 03/06/2021 |
| RENOVACARE, INC. | Chief Executive Officer | 25/03/2021 |
| EMISPHERE TECHNOLOGIES, INC. | Chief Executive Officer | 15/10/2019 |
New American Therapeutics, Inc.
 New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Chief Executive Officer | 01/07/2012 |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Chief Executive Officer | 01/09/2010 |
Formazione di Alan Rubino
| Rutgers State University of New Jersey | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| W WORL | Health Technology |
| VERICEL CORPORATION | Health Technology |
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| RENOVACARE, INC. | Health Technology |
| SANUWAVE HEALTH, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Health Technology |
| HealthCare Institute of New Jersey | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Health Technology |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
Hoffmann-La Roche Ltd.
 Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The private company is based in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Alan Rubino
